Mild cognitive impairment (MCI) means noticeable memory or thinking decline beyond normal aging, yet daily tasks remain manageable. It does not always progress to dementia. The Alzheimer's Association describes it as an intermediate stage between normal aging and dementia. About 12-18% of adults age 60 and older live with it, so it is common but not the same as dementia.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How does MCI differ from aging and dementia?
- Does MCI always lead to dementia?
- What raises risk and how is it diagnosed?
- What can you do after a diagnosis?
How does MCI differ from aging and dementia?
Misplacing keys sometimes is normal aging. MCI means changes are greater than expected for age and noticed by you or family. The Alzheimer's Association states in its MCI topic sheet that people can still independently perform most daily activities.
Amnestic MCI mainly affects memory, such as recalling recent conversations or appointments. Nonamnestic MCI affects other skills, such as language, attention, or visuospatial skills. Visuospatial means judging shapes, distances, and places.
Does MCI always lead to dementia?
No. UNSW Newsroom summarized peer-reviewed evidence in its MCI progression summary that about 6-11% develop dementia per year and about 40% within five years.
That compares with 1-2% per year in the general older population. Many people stay stable for years. A Dementia in Home review citing the Alzheimer's Association reports in its MCI stability review that 14.4-55.6% revert to normal cognition in reviewed studies, and about 30% in population studies.
What raises risk and how is it diagnosed?
The National Institute on Aging notes there is no single cause. Risk rises with age plus diabetes, depression, stroke, vascular disease, APOE-e4 genetics, certain medications, and sleep or psychiatric conditions. APOE-e4 is a gene variant linked to higher Alzheimer's risk.
The Mayo Clinic notes no single test diagnoses MCI. Diagnosis uses medical history, family input, cognitive and neurologic exams, lab tests, and brain imaging. Sometimes it adds amyloid PET or spinal-fluid testing. Amyloid PET is a brain scan that shows an Alzheimer's-linked protein, while spinal-fluid testing analyzes fluid around the brain and spine.
What can you do after a diagnosis?
The National Institute on Aging advises acting on factors you can change. Useful steps include: Repeat cognitive checks about every 6-12 months. Bring a family member to visits to report changes you may miss.
- Treat reversible contributors and review medications with your doctor
- Control blood pressure and diabetes
- Exercise regularly and eat healthfully
- Stay socially and mentally active
